Abstract
Some immigrant groups in Europe show an increased prevalence of diabetes, e.g. South Asians in the UK and Moroccans and Turks in the Netherlands. This study aimed at reviewing the literature among immigrants in the Nordic countries. Search was performed primarily of Medline through PubMed, and secondarily of other databases and by using information from reference lists. Terms used were: “Diabetes Mellitus”, “Immigrant”, and “Nordic countries” or “Scandinavia” or “Denmark”, “Finland”, “Iceland”, “Norway” or “Sweden”. Altogether 17 articles on diabetes were found. Excess risk of diabetes was found in non-European immigrant groups, especially from the Middle East and South Asian regions, in some cases 10 times the risk of the indigenous population, with the highest relative risks among women. No excess risk was found among European immigrants, with the possible exception of Finnish women. Conflicting results were found in studies with a low number of diabetic cases, with a failure to show statistically significant excess risks among non-European groups. There were also some other methodological problems, e.g. low participation rate in populationbased clinical studies, and probable underestimation of known diabetes by self-report. A genetic sensitivity seems likely in the Middle East and South Asian groups, combined with lifestyle factors.
Keywords: Diabetes mellitus, Immigrants, Prevalence, Nordic countries
Current Diabetes Reviews
Title: Prevalence of Diabetes Among Immigrants in the Nordic Countries
Volume: 6 Issue: 2
Author(s): Per E. Wandell, Axel C. Carlsson and Kristin H. Steiner
Affiliation:
Keywords: Diabetes mellitus, Immigrants, Prevalence, Nordic countries
Abstract: Some immigrant groups in Europe show an increased prevalence of diabetes, e.g. South Asians in the UK and Moroccans and Turks in the Netherlands. This study aimed at reviewing the literature among immigrants in the Nordic countries. Search was performed primarily of Medline through PubMed, and secondarily of other databases and by using information from reference lists. Terms used were: “Diabetes Mellitus”, “Immigrant”, and “Nordic countries” or “Scandinavia” or “Denmark”, “Finland”, “Iceland”, “Norway” or “Sweden”. Altogether 17 articles on diabetes were found. Excess risk of diabetes was found in non-European immigrant groups, especially from the Middle East and South Asian regions, in some cases 10 times the risk of the indigenous population, with the highest relative risks among women. No excess risk was found among European immigrants, with the possible exception of Finnish women. Conflicting results were found in studies with a low number of diabetic cases, with a failure to show statistically significant excess risks among non-European groups. There were also some other methodological problems, e.g. low participation rate in populationbased clinical studies, and probable underestimation of known diabetes by self-report. A genetic sensitivity seems likely in the Middle East and South Asian groups, combined with lifestyle factors.
Export Options
About this article
Cite this article as:
Wandell E. Per, Carlsson C. Axel and Steiner H. Kristin, Prevalence of Diabetes Among Immigrants in the Nordic Countries, Current Diabetes Reviews 2010; 6 (2) . https://dx.doi.org/10.2174/157339910790909404
DOI https://dx.doi.org/10.2174/157339910790909404 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Clinical, Molecular, and Genetic Characteristics of PAPA Syndrome: A Review
Current Genomics Beta-Blockers for the Treatment of Essential Hypertension: What are the Arguments Against Their Use as First Line Therapy?
Current Hypertension Reviews Cardiovascular Benefit of SGLT2 Inhibitors in the Therapeutics of Diabetes Mellitus: A Close Look beyond the Horizon
Current Drug Targets Clinical Applications of Transcranial Doppler Sonography
Reviews on Recent Clinical Trials Neuronal Response of Peroxisomal and Peroxisome-Related Proteins to Chronic and Acute Aβ Injury
Current Alzheimer Research The Posttranslational Phase of Gene Expression: New Possibilities in Molecular Diagnosis
Current Molecular Medicine Beneficial Effects of Statins on Endothelial Dysfunction and Vascular Stiffness
Current Vascular Pharmacology Oxidative Stress Mediated Mitochondrial and Vascular Lesions as Markers in the Pathogenesis of Alzheimer Disease
Current Medicinal Chemistry Recent Progress in Mutation-driven Therapy, Immunotherapy and Combination Therapy for the Treatment of Melanoma
Current Cancer Drug Targets The Need for Physiologically Relevant Peroxisome Proliferator-Activated Receptor-gamma (PPAR-γ) Ligands
Endocrine, Metabolic & Immune Disorders - Drug Targets Pharmacologic Treatment for Prehypertension: To Treat or Not to Treat?
Recent Patents on Cardiovascular Drug Discovery Editorial (Thematic Issue: AMPK: New Frontiers in Human Diseases)
Current Drug Targets Glycation of Human Serum Albumin in Diabetes: Impacts on the Structure and Function
Current Medicinal Chemistry Clinical Review: Safety and Efficacy Comparison between Sulfonylureas and Dipeptidyl Peptidase-4 Inhibitors as Second-Line Therapies in Type 2 Diabetes Mellitus
Current Pharmaceutical Design Advanced Glycation End Products in Chinese Medicine Mediated Aging Diseases: A Review
Current Vascular Pharmacology Association of Hypothyroidism with Body Mass Index, Systolic Blood Pressure and Proteinuria in Diabetic Patients: Does treated Hypothyroidism with Thyroxine Replacement Therapy Prevent Nephropathy/Chronic Renal Disease?
Current Diabetes Reviews CPP-conjugated Anti-apoptotic Peptides as Therapeutic Tools of Ischemiareperfusion Injuries
Current Pharmaceutical Design Targets for the Treatment of Erectile Dysfunction: Is NO/cGMP Still the Answer?
Recent Patents on Cardiovascular Drug Discovery Risk of Vertical HIV Transmission Combines the ‘B35-Cw4 Disadvantage’ and the ‘Pattern of Inheritance’ Theories of Progression
Current HIV Research Diabetes and the Chronic Care Model: A Review
Current Diabetes Reviews